2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial.

Anant Narayan BhattSrinivas ShenoySagar MunjalVijayakumar ChinnaduraiApurva AgarwalA Vinoth KumarA ShanavasRatnesh KanwarSudhir Chandna

Published in: BMC infectious diseases (2022)

CTRI, CTRI/2020/06/025664. Registered 5th June 2020, http://ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=44369&EncHid=&modid=&compid=%27,%2744369det%27 .

Keyphrases

phase ii
clinical trial
open label
healthcare
double blind
coronavirus disease
sars cov
placebo controlled
phase iii
palliative care
study protocol
quality improvement
blood glucose
randomized controlled trial
pain management
adipose tissue
respiratory syndrome coronavirus
type diabetes
skeletal muscle